for reconsideration in light of the "positions asserted by the parties in their supplemental briefs". Because the Petitioners agreed that "their religious exercise is not infringed where they 'need to do nothing more than contract for a plan that does not include coverage for some or all forms of contraception'", the Court held that the parties should be given an opportunity to clarify and refine how this approach would work in practice and to "resolve any outstanding issues". The Supreme Court expressed "no view on the merits of the cases." In a concurring opinion, Justice Sotomayor, joined by Justice Ginsburg noted that in earlier cases "some lower courts have ignored those instructions" and cautioned lower courts not to read any signals in the Supreme Court's actions in this case. In 2017, the Trump administration issued a ruling letting insurers and employers refuse to provide birth control if doing so went against their religious beliefs or moral convictions. However, later that same year federal judge Wendy Beetlestone issued an injunction temporarily stopping the enforcement of the Trump administration ruling. Current practices There are many types of contraceptive methods available. Hormonal methods which contain the hormones estrogen and progestin include oral contraceptive pills (there is also a progestin only pill), transdermal patch (OrthoEvra), and intravaginal ring (NuvaRing). Progestin only methods include an injectable form (Depo-Provera), a subdermal implant (Nexplanon), and the intrauterine device (Mirena). Non-hormonal contraceptive methods include the copper intrauterine device (ParaGard), male and female condoms, male and female sterilization, cervical diaphragms and sponges, spermicides, withdrawal, and fertility awareness. As of 2008, in the United States, 99% of sexually active women have used birth control at some point in time. In 2006–2008, the most popular contraceptive methods among those at risk of unintended pregnancy were oral contraceptive pills (25%), female sterilization (24.2%), male condoms (14.5%), male sterilization (8.8%), intrauterine device (4.9%), withdrawal (4.6%). Depo-Provera is used by 2.9%, primarily younger women (7.5% of those 15-19 and about 4.5% of those 20–30). A 2013 Lancet systematic literature review found that among reproductive aged women in a marriage or union, 66% worldwide and 77% in the United States use contraception. Due to this, unplanned pregnancies in the United States are at the lowest they have ever been throughout history. However, unintended pregnancy remains high; in 2011, 45% of pregnancies were unintended. 10.6% of women at risk of unintended pregnancy did not use a